MedTrace Logo

Study of Acarbose in Longevity

NCT02953093 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2025-06-24

Study results available
· View outcomes & findings →

Summary

The investigators are studying the effects of acarbose on muscle and adipose gene transcription in older adults.

Conditions

  • Aging

Interventions

DRUG

Acarbose

see arm description

OTHER

Placebo

See arm description

Sponsors & Collaborators

  • Glenn Foundation for Medical Research

    collaborator UNKNOWN

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Nir F Barzilai, MD · Albert Einstein College of Medicine Montefiore Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Max Age
100 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-30
Primary Completion
2019-04-20
Completion
2019-12-26
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02953093 on ClinicalTrials.gov